Publishers Weekly Reviews
The fierce, global competition for a share of the $25 billion analgesic trade based on aspirin, the 100-year-old, multipurpose drug, and its derivatives (Bufferin, Alka Seltzer etc.), and rival analgesics (Tylenol, Advil etc.) is vividly recounted here by Mann (coauthor of The Second Creation ) and economist Plummer. They portray such scientists as German chemist Carl Duisberg, who developed aspirin from a form of coal tar, and recall WW I- and WW II-connected international episodes concerning aspirin's exploitation, along with court battles between manufacturers and suits brought against them for false claims by federal regulatory agencies. The authors of this significant report note that while researchers are still probing the secrets of how aspirin works, recent studies have confirmed its value for prevention and treatment of heart attacks and strokes, further intensifying competition among analgesic manufacturers. Photos. (Nov) Copyright 1991 Cahners Business Information.
Traces the story of aspirin, a wonder drug that has survived virtually unchanged over the course of a century of competition, hucksterism, and corporate skulduggery - (Baker & Taylor)